Key facts
- This page summarizes Andrew Hykes's Form 4 filing for Inari Medical, Inc..
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 21 Feb 2024, 21:52.
Andrew Hykes - 16 Feb 2024 Form 4 Insider Report for Inari Medical, Inc.
- Reporting relationship
- President and CEO, Director
- Issuer ticker
- N/A
- Reported as of
- 16 Feb 2024
- Net transaction value
- +$2,611,859
- SEC form
- 4
- Accepted by SEC
- 21 Feb 2024, 21:52:32 UTC
- Prior SEC filing
- 03 Jan 2024
- Next SEC filing
- 03 Apr 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Shannon Trevino, attorney-in-fact for Andrew Hykes
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Andrew Hykes filed Form 4 for Inari Medical, Inc. on 21 Feb 2024.
Change
- Previous filing in this sequence was filed on 03 Jan 2024.
- Current net transaction value: +$2,611,859.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NARI
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +40,786
- Change %
- +9.4%
- Price
- $0.000000
- Shares after
- 472,696
- Date
- 16 Feb 2024
- Ownership
- Direct
- Footnotes
- F1, F2
NARI
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,550
- Date
- 16 Feb 2024
- Ownership
- By Child 1
NARI
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,550
- Date
- 16 Feb 2024
- Ownership
- By Child 2
NARI
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,550
- Date
- 16 Feb 2024
- Ownership
- By Child 3
NARI
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,000
- Date
- 16 Feb 2024
- Ownership
- By Spouse
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NARI
transaction
Derivative
Stock Options (Right to Buy)
Award
- Transaction value
- $2,611,859
- Shares
- +44,693
- Change %
- Price
- $58.44
- Shares after
- 44,693
- Date
- 16 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 44,693
- Exercise price
- $58.44
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents annual restricted stock units ("RSUs") awarded to the reporting person, with a vesting commencement date of January 1, 2024 (the "Vesting Commencement Date"). 1/16th of the RSUs shall vest on each quarterly anniversary of the Vesting Commencement Date, subject to continued service through the applicable vesting date.
Footnote F2
Includes 156 shares acquired on January 31, 2024, under the Company's Employee Stock Purchase Plan.
Footnote F3
Represents options to purchase shares of Issuer common stock which were granted on February 16, 2024 under the Issuer's 2020 Incentive Award Plan and are scheduled to become vested and exercisable on a quarterly basis, with the first tranche vesting on April 1, 2024.